TD Cowen lowered the firm’s price target on Enovix (ENVX) to $7 from $10 and keeps a Hold rating on the shares. The firm said the company is on track to deliver custom cells for smartphones later this year with first qual deliveries scheduled in 2Q.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVX:
- Enovix’s Breakthrough in Energy Density and Strategic Expansion Positions It as a Compelling Buy
- Enovix: Strong Growth Potential and Strategic Advancements Justify Buy Rating
- Enovix Corporation Reports Q1 2025 Financial Results
- Enovix Hold Rating: Balancing Technological Progress and Financial Challenges Amidst Intensifying Competition
- Enovix reports Q1 EPS (12c), consensus (17c)